Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
‘Tis the season to have your own pharma-themed film festival
Posted on December 23rd, 2019 by Xuanyan Xu in Pharma R&D
The warmest family celebration of the year is almost here! All my friends and colleagues around me have started thinking about the best ways to spend this year’s family gathering. Well, if you are like me—a geeky introvert who enjoys time alone—nothing goes better with family parties and eating huge amounts of food than relaxing on the couch and binge-watching movies and TV shows.
Throughout the year, I have come across some great movie suggestions, so I’ve made a short list for this Christmas holiday season. And today I am sharing with you my 2019 Christmas movie bucket list. If you have watched them, do let me know your thoughts. If you have better suggestions, let me know too! (Note: These are my own views, and don’t reflect the views of Elsevier.)
This is a 2018 Chinese comedy-drama film about a leukemia patient who smuggled cheap but unproven cancer medicine from India for 1,000 Chinese cancer sufferers in 2004. One of the highest-grossing films in Chinese box office history, Dying to Survive is widely considered the best movie of 2018. More importantly, the film sparked a debate about the cost of medical care among Chinese people, and urged regulators to “speed up price cut for cancer drugs” and “reduce the burden on families”.
With a similar plot to Dying to Survive, but released in 2013, Dallas Buyers Club is about a cowboy diagnosed with AIDS, who discovers a banned drug that can help patients survive longer. To get around the system, he forms a club to smuggle the medicine to those in need. It has received universal acclaim, with an “incredible life story, told with a dash of humor and an empathy-evoking narrative. Brilliant would be an understatement”.
Starring big names like Jude Law, Channing Tatum and Catherine Zeta-Jones, Side Effects is an unsettling psychological thriller about a woman who is prescribed experimental drugs by psychiatrists and experiences unexpected side effects. Although Side Effects is not based on a true story, it was a well-reviewed movie that offers some provocative commentary about mental health and the pharma industry.
150 Milligrams (La Fille de Brest)
I’m a big fan of the Toronto International Film Festival, which combines Hollywood studio premieres and some independent productions, providing a go-to source for new movies. Screened in the festival’s special presentations section in 2016, this movie was based on the true story of the diabetes drug Mediator. The drug was withdrawn on 18 December 2009, based on the European Medicines Agency’s recommendation, because its risks—particularly the risk of heart valve disease—were deemed greater than its benefits. This story is about French pulmonologist Irène Frachon and her investigation of the drug’s serious side effects.
This award-winning HBO documentary focuses on Sam Berns, a teenager with progeria, a rare and fatal genetic disease sometimes known as ‘premature aging syndrome.’ It also highlights the work of his mother, Dr. Leslie Gordon, who has worked to research and find a treatment for the incurable disease, and other kids with progeria who have taken part in clinical trials.
Netflix released this documentary TV series just this past summer, and it features Dr. Lisa Sanders, a primary care physician and New York Times columnist. In each episode, Dr. Sanders spotlights a person who is suffering from an undiagnosed condition and guides them through a process of crowdsourcing ideas on what could be causing their mysterious symptoms. In the age of Web MD and telemedicine, it is an intriguing concept!
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Sr. Marketing Manager, Life Sciences Audience at Elsevier
- Personal Health Train initiative gives researchers data access FAIRly
- Unlocking the potential of the Reaxys PhD prize – insights from 4 winners and finalists
- 3 issues global pharmas should consider as the coronavirus outbreak continues
- What’s ahead for the Life Sciences industry?
- Global Dominance in AI? China’s Got a Plan For That